Obesity and hyperiension frequently develop after heart trans . plantation . The cardiac adaptation m ohesny and hyperersinn was studied by determining hemodynamic and echaardiographic indexes in 10 obese hypertensive patient (body gno index =_27 .8 kill." in coon or x27.3 t/ghar in women) matched hp mean arterial pressure, age and gender with 10 nonobese hypertenslve patients I year after cardiac transplantation . Cardiac output was 30'7 greater (p < 0 .02) and systemic vascular resistance 25% lower (p < 0.011 in the obese than in the nunubese patients. Right verricular systolic and pulmonary artery systolic, diastolic and mean pressures were also significantly higher ip -9 .95) in the obese patients . Left ventricular end-diastolic diameter was 25% greater (p < 0.05), left ventricular mass 28% greater (p ¢ 0 .02( Obesity and systemic arterial hypertension are two conditions that have been directly related . Thus, the incidence of hypeneusit o in an obese population is greater than that in a nonobese population (11. Furthermore, epidemiologic studies (I-4) have shown that obesity and hypertension are independent risk factors for congestive heart failure and other causes of cardiovascular morbidity and mortality . In the general population the heart adapts to obesity and hypertension by the development of eccentric left ventricular hypertrophy (that is . left ventricular dilation and an increase in left ventricular mass) fl)-Heart transplantation has became an accepted therapy for end-stage heart failure, particularly since cyclospotine was introduced as an immunosapprcssive agent (51 . However, patients treated with cyclosporine have a significantly increased prevalence of hypertension after transplantation compared with patients treated with azathiciprine and prednisene (6-91. In addition, after heart €ransplamation patients frequently gain weight, often to obesity (101 . This weight Cardiol 1992,19155-9) gain is certainly caused partly by an increase in appetite due to the use of prednisone in many immunosuppressive regimcns . Thus, partly in relation to their immunosuppressive therapy . many heart transplant patients develop both arterial hypertension and obesity . The purpose of the present study was to evaluate she cardiac adaptation to obesity and hypertension after heart transplantation by reviewing systemic hemedynamics, echocardiograms and ventricular function in nonobese and obese hypertensive ortholopie heart transplant recipients I year after traaspiantation .
and left ventricular enddiaMdic vulame 20% higher (p < 0 .01) In the obese subjects . Left ventricular ejectoo Iranians was sigat0 . canny lower in the Obese than in the nonobese subjects (34% vs. 51%,0,0.051.
These results indicate That Ike cardiac adaptation to obesity and hypertemion after ban transplantation consists of left ven, tricolor dilation and an increase in left ventricular mass associated with an increased cardiac output and lower peripheral vascular resistance . These adapt,ve changes that occur in obese hypnleasive patients after heart transplaotathm might increase the hmgterm elk of graft failure, as suggested by O+er lower left ventricular ejection fraction I year after transplantation .
(J Am Coo Cardiol 1992,19155-9) gain is certainly caused partly by an increase in appetite due to the use of prednisone in many immunosuppressive regimcns . Thus, partly in relation to their immunosuppressive therapy . many heart transplant patients develop both arterial hypertension and obesity . The purpose of the present study was to evaluate she cardiac adaptation to obesity and hypertension after heart transplantation by reviewing systemic hemedynamics, echocardiograms and ventricular function in nonobese and obese hypertensive ortholopie heart transplant recipients I year after traaspiantation .
Methods
Patient selecoeo. The study group consisted of 20 hypertensive patients who were evaluated I year after orthotopic hear transplantation. Clinical evaluation and definition of hypertension (diastolic pressure >90 mm Hg measured by cuff method) followed established guidelines (11). Antihypertensive agents prescribed for these patients consisted of either a calcium channel blocking agent, an angiotensinconverting enzyme inhibitor or a central acting agent. Body mass index was calculated as weight in kgfheight in m z and patients were classified into obese and nonobese groups by using partition values for body mass index (?27 .8 kgfm2 for men and X27 .3 kg/mz for women) representing the 85th percentile of values according to the National Health and Nutrition Evaluation Survey 11 (12 were matched by mean artery) pressur , age and gender Table 1 . Baseline Characteristics of 20 Paneots Undergoing formed the study group . Most patients were receiving immunosoppressive therapy with cyclosporine, prednisone and azathioprine. Two patients in the *best group and three patients in the nonobese group were receiving cyclesporine and prednisone only . No patient had acute allograft rejection or angiographic evidence of allograft arterinpathy at the time of the studyHemodynamic evaluation. The hemodynamic values were measured at the time of the endomyocardial biopsy as previously reported 113) . Right heart pressures were measured with use of a balloon-tipped pulmonary artery catheter . Cardiac output was measured in triplicate by the thermodilution method ; the average of the three values sins recorded . Mean arterial pressure was calculated from cuN'bleod pressure readings by adding one third of the pulse pressure to the diastolic blood pressure . Systemic vascular resistance was calculated with the following formula;
Mean arterial pressure -Mean right atria) pressure ----x go . Cardiac output Definition and diagnosis of rejection . The diagnosis of acute rejection was made on the basis of the histologic changes observed on endomyocardial biopsy sample . (13) . Briefly, rejection was graded as mild, moderate: or severe according ' .o the degree of the lymphncytic infiltrate and myocyte mrcrosis (13) .
Echocardiographic evaluation . Echocardiography was perforated after the right heart catheterization and endesmyocardial biopsy. Echocardiographic measurements were made according to the iceommendations of t2a American Society of Echocardiography (14) . Left ventricular enddiastolic diarnnter and the thickness of the interventricular septum and left ventricular posterior wall were measured at the end of diastole, as defined by the onset of the QRS complex . Left ventricular mass was calculated with use of the formula of Troy et al . (15) . Left ventricular volumes were estimated by the method of Teichholz et al . (16) and peak systolic stress was measured by the noninvasive method of Wilson er Id. (17) . Ventrieolar runlet;nn; Right and left ventricular function were evaluated with use of radionuclide angiographic techniques, as previously described (18) .
Renal function. Serum creatinine and creatininc clearance were measured in all study patients 1 year after orlitotopic heart transplantation and were used as indicators of renal function.
Statistical analysis, Data are reported as mean values SD. Unpaired Student's r tests were used to compare clinical, hemodynamic, echocardiographic and ventricular function variables of nonobese and obese hypertensive ortholopic heart transplant recipients. ' There went ou signilcunr diiferenxs between goups in the baseline characrencsscunr d
Results
Patient characteristics (Tables 1 and 2 ). At the time of heart transplantation there was no difference in baseline weight. mean arterial pressure and ejection fraction between the two groups ( Table 1 ) . The nonobese and obese hypertensive patient groups at I year after heart transplantaton were matched by mean arterial pressure, age and gender it .' the two groups also did not differ with respect to height . By' design of the study, weight, body surface area and body mass index were sign'ifirarsay ^realer in the obese peyrtrs . Renal function and the number of rejection episodes per patient were similar in oonobesc and obese patients ( Table  2) .
Hemodynaoic indexes (Tables 2 and 3 ) . At 1 You after orthetepic heart transplantation, obese patients in comparison with nonobese patients were characterised by a significantly higher cardiac output (30%. p < 0.02) and lower systeric vascular resistance (25%, p < 0,01) at the same level of mean arterial pressure-In addition, right ventricular systolic pressure and pulmonary artery systolic, diastolic and mean pressures were significantly higher in the obese patients (p < 0.05) . At I year after orthelopic heart transplantation . obese patients, when compared with nonobese patients with similar mean systolic arterial pressure, had a significantly higher cardiac output (6 ± 1 vs . 4.6 ± 0 .8 tiletsrmin ; p < 0 .02) and lower systemic vascular resistance (1,413 ^ 18 vs . 1,881 -' 19 dynes/s per cm -' ; p < 0.01 ; (Table 3) . Cardiac output correlated significantly with body mass index (r = O .6t : n < 0 .004) . Table 3 . Postoperative Hemodynamic Values I Year After an increased cardiac erttpur, left ventricular dilation and a lower ejection fraction at I year after transplantation . Hypertension after heart transplantation . Arterial hypertension is a serious and frequent complication of cyclosporine therapy in heart transplant recipients (7) . In orthotopic heart transplant recipients, hypertension is detected as early as the 1st postoperative week (19) , is frequently established by 50 days postoperatively (7) and has been reported to occur in 38% to 92% of such recipients (20) (6,20 .21 ). An association between hypertension after transplantation, renal insufficiency and increased plasma volume has been reported (7) but this finding has not been confirmed in other studies (9) . Because patients with cyclospodne-induced hypertension do rut have a nocturnal decrease in blood pressure, it has also been suggested that abnormal central nervous system control of blood pressure may play a role in the development of hypertension after transplantation (7.2)-TTie :,-eight gain induced by cardroateroids may also contribute to the development of increased blood pressure after orthotopic heart transplantation . The results of some previous studies (23) suggest that the blood pressure decreases and fewer anti hypertensive medications are required in patieuts who can be withdrawn from corticosteroid therapy . Moreovcr, patients who gain the least weight after cardiac transplantation are more likely to remain normotensivc (9) .
Previous studies have reported an abnormal left ventricular cud-diastolic pressure, a lower ejection fraction (24) and the development of cuuceninc left ventricular hypertrophy 1251 in hypertensive patients I year after orhoropic heart tansplantation .
Role of obesity. Obesity, as defined by an excess of frady fat, has been shown to increase total body oxygen demands . To meet this demand, cardiac output, blood volume and preload increase in obese patients regardless of the level of arterial pressure (26-301 . [o addition, obesity may also lead to altered systolic and diastolic performance (31-33) .
The increased cardiac output observed in our obese recipients 1 year after orthotopic heart transplantation is it . accord with previous findings (26-30) . Because we did not measure total blood volume, the mechanism of the increased cardiac output remains speculative . However, it seems likely that in these patients the increased left ventricular end-diastulic volume is produced by an increase in preload (26, 27) . Heart rate and stroke volume were also somewhat higher in obese patients, thus contributing to the significant increase in cardiac output .
In the general population, arterial hypertension detected Heart Transplantation VENTURA ET AL .
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Myocardial structure and function ( Table 4) . As measured by echocardiography and radionuclide angiegraphy at I year after orthotopic heart transplantation . obese patients had a significantly greater left venricular end-diastulic diameter (25% ; 6.0 a 0.1 vs . 4.8 . 0.3 em ; p < 0 .05) and end-diastolic volume (20% : 135 ± 10 vs . 106 a 5 ml ; p 0.011 and a greater left ventricular mass (28`70 ; 312`-7 '. 241 ± 7 g : p e-0 .22) and Itft ventric<1ar :nasslhcight ratio (27% ; 181 ± 3 vs . 145 ± 3 elm) at the same level of arterial pressure Wig . I) . Left ventricular mass correlated significantly with body m :: ; index Cr = 0.6; p < 0.0041. There were no differences in posterior wall or septal thickness . Peak systolic stress, although higher in the obese group, did not achieve statistical significance (fable 4) . The left ventricular ejection fraction was significantly lower in the obese patients (33% ; 34 ! 4 vs . 51 a 3% ; p < 0.05) .
Discussion
The results of our study indicate that the cardiac adaptation to hypertension after transplantation in cyclosporinetreated patients differs in nonnbese and obese patients . Compared with nonnbese hypertensive orthotopic heart transplant recipients, obese heart transplant recipients have (34) (35) (36) (37) . Furthermore, the results of recent studies suggest that increased left ventricular mass is an independent risk factor for cardiovascular events 136,37) . In nonobese individuals in the general population . the adaptation to arterial hypertension consists of ventricular hypertrophy without chamber dilation, that is, coaxidric left ventricular hypertrophy 11) . In contrast. in obese patients the adaptation to hypertension includes the development of hypertrophy and vent icular dilation or eccentric left ventrieutar hypertrophy 11,38) . Because of the increased preload and the concomitant systolic and diastolic abnormalities, patients who are both obese and hyperlensive may be at higher risk for developing premature congestive heart failure, ventricular arrhythmias (391 and other cardiovascular complications (1) . The cardiac adaptation to obesity and hypertension after heart transplantation was characterized by an increased left ventricular mass and left ventricular end-diastolic diameter (eccentric left ventricular hypertrophy) . In fact, body mass index strongly correlated with left ventricular mass in this study group . These findings are similar to those of obese patients with essential hypertension.
Although body surface area has been used as an inn?ex of obesity . it has hero shown to underestimate hemndyma .mic variables and measurements of left ventricular struct ire.
Therefore, the use of height or ideal body surface area nosy provide a better index of body habitus (1434).
EJeclion fraction. The mechanism of decreased left ventricular ejection fraction in obese patients after heart transplantation remains speculative . An increase in the numberof rejection episodes can be postulated ; however, there was no difference between the groups jn our study . Therefore, either the increase in systolic stress not associated with an appmptiale increase in wall thickness or an inuinsic decrease in ventricular contractility can account for the lower ejection fraction.
Conclusions . The present study shows that after orthotopic bea(itansplantatioa obese hypertensive patients have a higher cardiac output and lower systemic vascular resistance at any given level of mean arterial pressure than do nonobese hypertensive patients . After orthotopic heart 59CC Vat . 19 
